NCT00121563View on ClinicalTrials.gov

Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

February 28, 2006

Conditions
Pain
Interventions
DRUG

Thalidomide, Ibuprofen or Diazepam

Trial Locations (1)

20892

National Institute of Nursing Research (NINR), Bethesda

All Listed Sponsors
lead

National Institute of Nursing Research (NINR)

NIH

NCT00121563 - Evaluation of a TNF-Alpha Modulator for Clinical and Molecular Indicators of Analgesic Effect | Biotech Hunter | Biotech Hunter